Andrew Freeman

1.3k total citations
29 papers, 986 citations indexed

About

Andrew Freeman is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Andrew Freeman has authored 29 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Genetics and 5 papers in Surgery. Recurrent topics in Andrew Freeman's work include Virus-based gene therapy research (7 papers), RNA Interference and Gene Delivery (4 papers) and 3D Printing in Biomedical Research (3 papers). Andrew Freeman is often cited by papers focused on Virus-based gene therapy research (7 papers), RNA Interference and Gene Delivery (4 papers) and 3D Printing in Biomedical Research (3 papers). Andrew Freeman collaborates with scholars based in United States, Australia and Spain. Andrew Freeman's co-authors include Richard M. Hoffman, Robert J. Huebner, Eva Engvall, Erkki Ruoslahti, R. Carlsson, Robert C. Pendleton, Paul J. Price, Matthew T. Rondina, Stuart A. Aaronson and George J. Todaro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and JNCI Journal of the National Cancer Institute.

In The Last Decade

Andrew Freeman

27 papers receiving 872 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Freeman United States 17 357 236 214 121 113 29 986
L A Harker United States 14 348 1.0× 153 0.6× 170 0.8× 72 0.6× 163 1.4× 24 1.6k
Hans Peter Schwarz Austria 22 306 0.9× 180 0.8× 97 0.5× 84 0.7× 120 1.1× 60 1.9k
Pascale Reverdiau France 21 420 1.2× 52 0.2× 236 1.1× 257 2.1× 84 0.7× 40 1.1k
Charles F. Brown United States 10 363 1.0× 219 0.9× 169 0.8× 28 0.2× 55 0.5× 14 882
M A Forbes United Kingdom 15 423 1.2× 78 0.3× 238 1.1× 146 1.2× 33 0.3× 29 1.1k
Heiko Rühl Germany 19 317 0.9× 87 0.4× 264 1.2× 35 0.3× 70 0.6× 92 1.8k
Masaru Ido Japan 18 277 0.8× 53 0.2× 200 0.9× 114 0.9× 65 0.6× 80 1.1k
David L. Becton United States 26 453 1.3× 135 0.6× 335 1.6× 62 0.5× 57 0.5× 61 1.9k
Shoji Haruta Japan 19 244 0.7× 76 0.3× 114 0.5× 113 0.9× 143 1.3× 60 1.3k
B A Fiedel United States 15 277 0.8× 51 0.2× 66 0.3× 50 0.4× 65 0.6× 37 948

Countries citing papers authored by Andrew Freeman

Since Specialization
Citations

This map shows the geographic impact of Andrew Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Freeman more than expected).

Fields of papers citing papers by Andrew Freeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Freeman. The network helps show where Andrew Freeman may publish in the future.

Co-authorship network of co-authors of Andrew Freeman

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Freeman. A scholar is included among the top collaborators of Andrew Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Freeman. Andrew Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yazer, Mark H., Andrew Freeman, Vincent P. Anto, et al.. (2021). Injured recipients of low‐titer group O whole blood have similar clinical outcomes compared to recipients of conventional component therapy: A single‐center, retrospective study. Transfusion. 61(6). 1710–1720. 30 indexed citations
3.
Aberegg, Scott K., Meghan M. Cirulis, Andrew Freeman, et al.. (2020). Clinical, Bronchoscopic, and Imaging Findings of e-Cigarette, or Vaping, Product Use–Associated Lung Injury Among Patients Treated at an Academic Medical Center. JAMA Network Open. 3(11). e2019176–e2019176. 33 indexed citations
4.
Freeman, Andrew, et al.. (2015). RNA Tumor Virus Genomes as Determinants of Chemically-Induced Transformation in vitro. Proceedings of the International Symposium on Comparative Leukemia Research. 39. 617–634.
5.
Freeman, Andrew, Humberto Bohórquez, Jorge Garces, et al.. (2014). Type 2 Diabetes Mellitus Recipients Achieved Excellent Outcomes in Simultaneous Kidney-Pancreas Transplantation Despite High Post-Operative Weight Gain.. Transplantation. 98. 857–858. 1 indexed citations
6.
7.
Pendleton, Robert C., Gwendolyn A. McMillin, Kristen K. Reynolds, et al.. (2012). Prospective pilot trial of PerMIT versus standard anticoagulation service management of patients initiating oral anticoagulation. Thrombosis and Haemostasis. 108(9). 561–569. 34 indexed citations
8.
Rogers, R. Kevin, Gregory J. Stoddard, Tom Greene, et al.. (2009). Usefulness of Adjusting for Clinical Covariates to Improve the Ability of B-Type Natriuretic Peptide to Distinguish Cardiac from Noncardiac Dyspnea. The American Journal of Cardiology. 104(5). 689–694. 22 indexed citations
9.
Freeman, Andrew & Richard M. Hoffman. (1986). In vivo-like growth of human tumors in vitro.. Proceedings of the National Academy of Sciences. 83(8). 2694–2698. 142 indexed citations
10.
Reuveny, Shaul, et al.. (1985). Newly developed microcarrier culturing systems--an overview.. PubMed. 60. 243–53. 3 indexed citations
11.
Reuveny, Shaul, A. Mizrahi, Mónica L. Kotler, & Andrew Freeman. (1983). Mammalian cell propagation on derivatized polyacrylamide microcarriers.. PubMed. 55. 11–23. 2 indexed citations
12.
Freeman, Andrew, et al.. (1981). Differentiation of fetal liver cells in vitro.. Proceedings of the National Academy of Sciences. 78(6). 3659–3663. 22 indexed citations
13.
Rasheed, S, Andrew Freeman, M. B. Gardner, & Robert J. Huebner. (1976). Acceleration of transformation of rat embryo cells by rat type C virus. Journal of Virology. 18(2). 776–782. 14 indexed citations
14.
Gordon, Robert J., et al.. (1973). Transformation of rat and mouse embryo cells by a new class of carcinogenic compounds isolated from particles in city air. International Journal of Cancer. 12(1). 223–232. 23 indexed citations
15.
Beverley, John, Andrew Freeman, & W. Watson. (1973). Comparison of a commercial toxoplasmosis latex slide agglutination test with the dye test. Veterinary Record. 93(8). 216–218. 5 indexed citations
16.
Price, Paul J., et al.. (1972). Transformation of Fischer Rat Embryo Cells by the Combined Action of Murine Leukemia Virus and (-)-Trans- 9-Tetrahydrocannabinol. Experimental Biology and Medicine. 140(2). 454–456. 12 indexed citations
17.
Aaronson, Stuart A., George J. Todaro, & Andrew Freeman. (1970). Human sarcoma cells in culture. Experimental Cell Research. 61(1). 1–5. 65 indexed citations
18.
Freeman, Andrew, Paul J. Price, Howard J. Igel, et al.. (1970). Morphological Transformation of Rat Embryo Cells Induced by Diethylnitrosamine and Murine Leukemia Viruses<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 44(1). 65–78. 77 indexed citations
19.
Freeman, Andrew, et al.. (1967). Transformation of primary rat embryo cells by adenovirus type 2.. Proceedings of the National Academy of Sciences. 58(3). 1205–1212. 98 indexed citations
20.
Eagle, Harry, Andrew Freeman, & Mina Levy. (1958). THE AMINO ACID REQUIREMENTS OF MONKEY KIDNEY CELLS IN FIRST CULTURE PASSAGE. The Journal of Experimental Medicine. 107(5). 643–652. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L A Harker Breakdown of academic impact, for papers by Hans Peter Schwarz Breakdown of academic impact, for papers by Pascale Reverdiau Breakdown of academic impact, for papers by Charles F. Brown Breakdown of academic impact, for papers by M A Forbes Breakdown of academic impact, for papers by Heiko Rühl Breakdown of academic impact, for papers by Masaru Ido Breakdown of academic impact, for papers by David L. Becton Breakdown of academic impact, for papers by Shoji Haruta Breakdown of academic impact, for papers by B A Fiedel
Rankless by CCL
2026